Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]
News [2740]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
Maintenance therapy with multi-targeted drug pazopanib delays relapse of...
Dr Andreas du Bois - Kliniken Essen Mitte, Germany
Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer ( Dr Andreas du Bois - Kliniken Essen Mitte, Germany )
1 Jun 2013
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2013
Treatment of primary central nervous system germinoma with chemotherapy
Dr Jonathan Finlay - Children's Hospital Los Angeles, USA
Treatment of primary central nervous system germinoma with chemotherapy ( Dr Jonathan Finlay - Children's Hospital Los Angeles, USA )
29 May 2013
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials
Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials ( Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
16 May 2013
Integrating breast cancer genomics and proteomics
Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013
Using chemo-radiotherapy without increasing toxicity
Dr Dirk De Ruysscher - Leuven University, Belgium
Using chemo-radiotherapy without increasing toxicity ( Dr Dirk De Ruysscher - Leuven University, Belgium )
15 May 2013
Approaches to treatment of brain metastasis
Dr Elisabetta Munzone - European Institute of Oncology, Milan, Italy
Approaches to treatment of brain metastasis ( Dr Elisabetta Munzone - European Institute of Oncology, Milan, Italy )
23 Apr 2013
Sapacitabine and seliciclib, antitumour activity in patients with incurable...
Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA
Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers ( Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA )
8 Apr 2013
Durable survival benefit for thalidomide consolidation in multiple myeloma post...
Dr Anna Kalff - Alfred Hospital, Melbourne, Australia
Durable survival benefit for thalidomide consolidation in multiple myeloma post ASCT ( Dr Anna Kalff - Alfred Hospital, Melbourne, Australia )
6 Apr 2013
Myeloma UK
Eric Low - Chief Executive, Myeloma UK
Myeloma UK ( Eric Low - Chief Executive, Myeloma UK )
6 Apr 2013
Hot topics at IMW 2013 - interactive discussion
Prof Philippe Moreau, Prof Jesus San Miguel
Hot topics at IMW 2013 - interactive discussion ( Prof Philippe Moreau, Prof Jesus San Miguel )
6 Apr 2013
Challenging paradigms in multiple myeloma
Prof Antonio Palumbo - University of Torino, Italy
Challenging paradigms in multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
6 Apr 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation